Document Detail


Transketolase-like protein 1 confers resistance to serum withdrawal in vitro.
MedLine Citation:
PMID:  20884117     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Transketolase-like protein 1 (TKTL1) is a member of the family of transketolase enzymes of which the founder member transketolase (TKT) is known to play a central role in the non-oxidative part of the pentose phosphate pathway. According to several publications TKTL1 is the only family member, whose expression is substantially de-regulated in a variety of solid tumours. Over-expression of TKTL1 correlates with poor prognosis of cancer patients and TKTL1 itself represents a potential therapeutic target owing to its possible involvement in the regulation of the proliferation and metabolism of cancer cells. We show that exogenously expressed TKTL1 provides HEK293 cells with moderate growth advantages under standard culture conditions, while protecting cells from growth factor withdrawal-induced apoptosis. Importantly, we identified TKTL1 with the JFC12T10 antibody as a 65kDa protein, which was however absent in most tumour cell lines tested. Primary head and neck squamous cell carcinomas of various localisations were characterised by a focal pattern with single cells strongly expressing TKTL1, rather than by a homogeneous expression pattern within the tumour mass.
Authors:
Diana Hartmannsberger; Brigitte Mack; Carola Eggert; Sabine Denzel; Herbert Stepp; Christian S Betz; Olivier Gires
Related Documents :
726547 - Promotion of l1210 tumour growth by macrophages.
9879547 - Kinetic characteristics of spontaneous lipid peroxidation in membranes isolated from no...
6654047 - Cell necrosis and endocytosis (apoptosis) in an embryonal rhabdomyosarcoma of the orbit.
11903597 - Thymic sarcomatoid carcinoma with skeletal muscle differentiation: report of two cases,...
17721067 - Role of the cholesterol biosynthetic pathway in osteoblastic differentiation.
6123537 - Theophylline and melanocyte-stimulating hormone effects on gamma-glutamyl transpeptidas...
Publication Detail:
Type:  Journal Article     Date:  2010-09-29
Journal Detail:
Title:  Cancer letters     Volume:  300     ISSN:  1872-7980     ISO Abbreviation:  Cancer Lett.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600053     Medline TA:  Cancer Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  20-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377 Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cavernous sinus syndrome, an atypical presentation of tertiary syphilis: case report and review of t...
Next Document:  Effects of cell condition, pH, and temperature on lead, zinc, and copper sorption to Acidithiobacill...